INZY
Price
$1.08
Change
-$0.09 (-7.63%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
76.18M
Earnings call today
TBPH
Price
$8.91
Change
+$0.11 (+1.25%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
440.01M
90 days until earnings call
Ad is loading...

INZY vs TBPH

Header iconINZY vs TBPH Comparison
Open Charts INZY vs TBPHBanner chart's image
Inozyme Pharma
Price$1.08
Change-$0.09 (-7.63%)
Volume$6.12K
Capitalization76.18M
Theravance Biopharma
Price$8.91
Change+$0.11 (+1.25%)
Volume$9.07K
Capitalization440.01M
INZY vs TBPH Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. TBPH commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and TBPH is a Buy.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (INZY: $1.18 vs. TBPH: $8.80)
Brand notoriety: INZY and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 81% vs. TBPH: 174%
Market capitalization -- INZY: $76.18M vs. TBPH: $440.01M
INZY [@Biotechnology] is valued at $76.18M. TBPH’s [@Biotechnology] market capitalization is $440.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both INZY and TBPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 6 TA indicator(s) are bullish while TBPH’s TA Score has 5 bullish TA indicator(s).

  • INZY’s TA Score: 6 bullish, 3 bearish.
  • TBPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, INZY is a better buy in the short-term than TBPH.

Price Growth

INZY (@Biotechnology) experienced а -20.81% price change this week, while TBPH (@Biotechnology) price change was -14.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.49%. For the same industry, the average monthly price growth was +10.87%, and the average quarterly price growth was -7.60%.

Reported Earning Dates

INZY is expected to report earnings on Aug 12, 2025.

TBPH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($440M) has a higher market cap than INZY($76.2M). TBPH YTD gains are higher at: -6.482 vs. INZY (-57.401). TBPH has higher annual earnings (EBITDA): -38.45M vs. INZY (-95.72M). INZY has more cash in the bank: 113M vs. TBPH (88.4M). INZY has less debt than TBPH: INZY (46.9M) vs TBPH (49.8M). TBPH has higher revenues than INZY: TBPH (64.4M) vs INZY (0).
INZYTBPHINZY / TBPH
Capitalization76.2M440M17%
EBITDA-95.72M-38.45M249%
Gain YTD-57.401-6.482885%
P/E RatioN/AN/A-
Revenue064.4M-
Total Cash113M88.4M128%
Total Debt46.9M49.8M94%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYTBPH
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA318.3820.12
+6.75%
Tesla
AAPL210.7912.52
+6.31%
Apple
SPY582.9918.65
+3.30%
SPDR® S&P 500® ETF
GME28.050.51
+1.85%
GameStop Corp
BTC.X102812.950000-1293.406200
-1.24%
Bitcoin cryptocurrency

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+2.61%
IGMS - INZY
49%
Loosely correlated
+5.31%
ERAS - INZY
48%
Loosely correlated
N/A
IDYA - INZY
47%
Loosely correlated
+5.34%
BEAM - INZY
47%
Loosely correlated
+4.77%
ASMB - INZY
47%
Loosely correlated
+0.90%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with ELEV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then ELEV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-2.00%
ELEV - TBPH
44%
Loosely correlated
+5.04%
KOD - TBPH
33%
Poorly correlated
+9.55%
IMCR - TBPH
30%
Poorly correlated
+4.01%
AUTL - TBPH
30%
Poorly correlated
+2.27%
INZY - TBPH
29%
Poorly correlated
+2.61%
More